New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding.
budding
colorectal cancer
histoprognostic factors
invasion front
isolated tumor deposits
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
10 Feb 2023
10 Feb 2023
Historique:
received:
02
12
2022
revised:
13
01
2023
accepted:
08
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
Colorectal cancer is a major public health issue due to its high incidence and mortality. It is, therefore, essential to identify histological markers for prognostic purposes and to optimize the therapeutic management of patients. The main objective of our study was to analyze the impact of new histoprognostic factors, such as tumor deposits, budding, poorly differentiated clusters, mode of infiltration, the intensity of inflammatory infiltrate and the type of tumor stroma, on the survival of patients with colon cancer. Two hundred and twenty-nine resected colon cancers were fully histologically reviewed, and survival and recurrence data were collected. Survival was analyzed using Kaplan-Meier curves. A univariate and multivariate Cox model was constructed to identify prognostic factors for overall survival and recurrence-free survival. The median overall survival of the patients was 60.2 months and the median recurrence-free survival was 46.9 months. Overall survival and recurrence-free survival were significantly worse in the presence of isolated tumor deposits (log rank = 0.003 and 0.001, respectively) and for an infiltrative type of tumor invasion (log rank = 0.008 and 0.02, respectively). High-grade budding was associated with a poor prognosis, with no significant difference. We did not find a significant prognostic impact of the presence of poorly differentiated clusters, the intensity of the inflammatory infiltrate or the stromal type. In conclusion, the analysis of these recent histoprognostic factors, such as tumor deposits, mode of infiltration, and budding, could be integrated into the results of pathological reports of colon cancers. Thus, the therapeutic management of patients could be adjusted by providing more aggressive treatments in the presence of some of these factors.
Identifiants
pubmed: 36834985
pii: ijms24043573
doi: 10.3390/ijms24043573
pmc: PMC9959523
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Br J Cancer. 2018 Nov;119(10):1244-1251
pubmed: 30385823
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17
pubmed: 24639052
Front Oncol. 2019 Nov 19;9:1255
pubmed: 31803624
Histopathology. 2015 Oct;67(4):464-73
pubmed: 25648412
Ann Surg Oncol. 2021 Jun;28(6):3408-3414
pubmed: 33105502
Ann Surg Oncol. 2012 Nov;19(12):3706-12
pubmed: 22669453
Anticancer Res. 2017 Jul;37(7):3817-3823
pubmed: 28668881
Am J Surg Pathol. 2015 Oct;39(10):1340-6
pubmed: 26200097
Am J Surg Pathol. 2016 Apr;40(4):544-53
pubmed: 26551623
Ann Transl Med. 2019 Dec;7(23):769
pubmed: 32042785
Dis Colon Rectum. 2012 May;55(5):509-14
pubmed: 22513428
Hum Pathol. 2021 Jan;107:9-19
pubmed: 32991929
Oncol Lett. 2016 Aug;12(2):1154-1158
pubmed: 27446411
Br J Cancer. 2018 Oct;119(7):785-792
pubmed: 30287914
Health Rep. 2018 Dec 19;29(12):21-25
pubmed: 30566206
J Clin Oncol. 2017 Apr 1;35(10):1119-1127
pubmed: 28029327
Dis Colon Rectum. 2008 May;51(5):568-72
pubmed: 18286339
Cancer Manag Res. 2018 Jul 04;10:1875-1887
pubmed: 30013394
Colorectal Dis. 2014 Apr;16(4):259-64
pubmed: 24118729
Mod Pathol. 2017 Sep;30(9):1299-1311
pubmed: 28548122
Hum Pathol. 2017 Jul;65:62-70
pubmed: 28438617
Br J Cancer. 2020 Apr;122(9):1367-1377
pubmed: 32157241
Int J Surg Case Rep. 2018;50:119-121
pubmed: 30103094
Eur J Cancer. 2017 Sep;82:92-102
pubmed: 28651160
Ann Surg Oncol. 2019 Jul;26(7):2037-2043
pubmed: 30949861
Ann Surg Oncol. 2018 Oct;25(11):3179-3184
pubmed: 30083832
Histopathology. 2018 Apr;72(5):721-728
pubmed: 28960400
Arq Gastroenterol. 2020 Apr-Jun;57(2):172-177
pubmed: 33206858
Eur J Surg Oncol. 2015 Mar;41(3):300-8
pubmed: 25468456
Mod Pathol. 2013 Aug;26(8):1123-31
pubmed: 23060121
Clin Cancer Res. 2018 Mar 1;24(5):1062-1072
pubmed: 29180604
Crit Rev Oncol Hematol. 2017 Apr;112:11-20
pubmed: 28325252
Sci Rep. 2020 Feb 25;10(1):3360
pubmed: 32099066
J Gastrointest Surg. 2016 Mar;20(3):648-55
pubmed: 26573851
Crit Rev Oncol Hematol. 2014 Apr;90(1):77-90
pubmed: 24332522
J Gastrointest Cancer. 2015 Sep;46(3):212-8
pubmed: 25994502
Dis Colon Rectum. 2010 Jan;53(1):57-64
pubmed: 20010352
Curr Treat Options Oncol. 2017 Apr;18(4):23
pubmed: 28391421
Clin Colorectal Cancer. 2017 Mar;16(1):9-15
pubmed: 27444718
Virchows Arch. 2014 Jun;464(6):655-62
pubmed: 24771119
Am J Surg Pathol. 2018 Jun;42(6):705-714
pubmed: 29624511